Geode Capital Management
XBIT icon

Geode Capital Management’s XBiotech XBIT Stock Holding History

Geode Capital Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$543K Buy
231,020
+9,899
+4% +$23.9K ﹤0.01% 3556
2025
Q4 		$529K Sell
221,121
-742
-0.3% -$1.83K ﹤0.01% 3565
2025
Q3 		$590K Buy
221,863
+1,184
+0.5% +$3.51K ﹤0.01% 3556
2025
Q2 		$656K Sell
220,679
-240,551
-52% -$699K ﹤0.01% 3467
2025
Q1 		$1.49M Buy
461,230
+6,703
+1% +$23.1K ﹤0.01% 3158
2024
Q4 		$1.8M Buy
454,527
+2,263
+0.5% +$15.4K ﹤0.01% 3170
2024
Q3 		$3.5M Buy
452,264
+22,059
+5% +$145K ﹤0.01% 2933
2024
Q2 		$2.21M Buy
430,205
+235,001
+120% +$1.81M ﹤0.01% 3099
2024
Q1 		$1.59M Buy
195,204
+2,616
+1% +$15K ﹤0.01% 3201
2023
Q4 		$771K Buy
192,588
+9,850
+5% +$39.2K ﹤0.01% 3447
2023
Q3 		$753K Buy
182,738
+9,557
+6% +$47.8K ﹤0.01% 3441
2023
Q2 		$1.03M Buy
173,181
+18,098
+12% +$81.7K ﹤0.01% 3339
2023
Q1 		$535K Hold
155,083
– – ﹤0.01% 3620
2022
Q4 		$544K Buy
155,083
+3,342
+2% +$11.4K ﹤0.01% 3629
2022
Q3 		$549K Buy
151,741
+345
+0.2% +$1.62K ﹤0.01% 3676
2022
Q2 		$852K Sell
151,396
-145,274
-49% -$977K ﹤0.01% 3497
2022
Q1 		$2.56M Sell
296,670
-12,711
-4% -$128K ﹤0.01% 3131
2021
Q4 		$3.44M Buy
309,381
+3,263
+1% +$42.5K ﹤0.01% 3096
2021
Q3 		$3.96M Buy
306,118
+8,196
+3% +$131K ﹤0.01% 3046
2021
Q2 		$4.93M Buy
297,922
+24,684
+9% +$419K ﹤0.01% 2921
2021
Q1 		$4.69M Buy
273,238
+32,851
+14% +$613K ﹤0.01% 2822
2020
Q4 		$3.76M Sell
240,387
-3,022
-1% -$55.7K ﹤0.01% 2743
2020
Q3 		$4.65M Sell
243,409
-18,252
-7% -$315K ﹤0.01% 2433
2020
Q2 		$3.59M Sell
261,661
-14,997
-5% -$211K ﹤0.01% 2512
2020
Q1 		$2.94M Sell
276,658
-59,821
-18% -$974K ﹤0.01% 2456
2019
Q4 		$6.28M Buy
336,479
+32,547
+11% +$419K ﹤0.01% 2310
2019
Q3 		$3.18M Buy
303,932
+5,976
+2% +$48.7K ﹤0.01% 2654
2019
Q2 		$2.26M Buy
297,956
+132,090
+80% +$1.15M ﹤0.01% 2875
2019
Q1 		$1.83M Buy
165,866
+30,703
+23% +$249K ﹤0.01% 2907
2018
Q4 		$686K Hold
135,163
– – ﹤0.01% 3253
2018
Q3 		$429K Buy
135,163
+8,086
+6% +$31.5K ﹤0.01% 3522
2018
Q2 		$569K Sell
127,077
-42,729
-25% -$193K ﹤0.01% 3391
2018
Q1 		$908K Buy
169,806
+3,631
+2% +$16.7K ﹤0.01% 3162
2017
Q4 		$654K Sell
166,175
-3,574
-2% -$15K ﹤0.01% 3258
2017
Q3 		$741K Buy
169,749
+7,136
+4% +$33.7K ﹤0.01% 3225
2017
Q2 		$764K Buy
162,613
+10,295
+7% +$98.6K ﹤0.01% 3213
2017
Q1 		$2.51M Buy
152,318
+7,066
+5% +$92.5K ﹤0.01% 2531
2016
Q4 		$1.47M Buy
145,252
+2,212
+2% +$29.4K ﹤0.01% 2803
2016
Q3 		$1.93M Buy
143,040
+82,209
+135% +$1.21M ﹤0.01% 2585
2016
Q2 		$1.27M Buy
60,831
+19,661
+48% +$284K ﹤0.01% 2768
2016
Q1 		$389 Buy
41,170
+639
+2% +$5.29K ﹤0.01% 3354
2015
Q4 		$440K Buy
40,531
+635
+2% +$8.11K ﹤0.01% 3332
2015
Q3 		$596K Buy
+39,896
New +$698K ﹤0.01% 3140

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management's XBIT Position: Q1 2026 in Review

Geode Capital Management increased its XBiotech (XBIT) stake by 4.5% in Q1 2026, buying an estimated $23.9K and bringing the position to 231,020 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #3556.

Geode Capital Management first reported a position in XBIT in Q3 2015 and has held it in 43 quarters since. The position peaked at $6.28M in Q4 2019. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Geode Capital Management held 231,020 shares of XBiotech worth $543K as of Q1 2026.
  • Geode Capital Management bought 9,899 XBiotech shares in Q1 2026, an estimated $23.9K.
  • XBiotech made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3556 holding.
  • Geode Capital Management first reported a position in XBiotech in Q3 2015 and has held it in 43 quarters since.
  • Geode Capital Management's XBiotech position peaked at $6.28M in Q4 2019.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.